https://www.targetedonc.com/view/cholangiocarcinoma-awareness-day-advances-in-frontline-and-later-btc-therapies
In an interview with Targeted Oncology™, Nathan Bahary, MD, PhD, discussed adapting to new therapy options and what the future holds for improving care for patients with cholangiocarcinoma.
Create an account
or login to join the discussion